Searched for
GLAND PHARMA CANCER TREATMENT
Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...- Cancer ♋ Weekly Horoscope (29th June - 5th July 2026): Unexpected Opportunities and Emotional Breakthroughs Await Cancer This WeekCancer Weekly Horoscope (29th June 2026 to 5th July 2026): Your Weekly Horoscope brings a week of important interactions. The Moon starts t...
- Mercury Retrograde July 2026: These 4 Zodiac Signs Could See an Ex Return When the Past Comes KnockingMercury Retrograde 2026 in Cancer beginning June 29, 2026 intensifies emotional memory loops, pulling unresolved relationships back into fo...
- Weekly Horoscope for ♋ CANCER (June 27 - July 3, 2026): Major Changes Begin as Your Birthday Season Gains MomentumCancer Weekly Horoscope (27th June 2026 to 3rd July 2026): Cancer, this week places you at the center of a powerful personal transformation...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- The Divine FlowThe writer recalls how her mother used to take a self-declared three-day "vacation" during menstruation, avoiding household work and spendi...
- Oil slide powers India's stock benchmarks to longest weekly winning run 7 monthsIndian stock markets achieved their longest winning streak in seven months, with the Nifty 50 and BSE Sensex closing higher. Falling crude ...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Ahead of Market: 10 things that will decide stock market action on WednesdaySensex and Nifty plunged over 1% on Tuesday amid global market weakness, IT sector losses, a weaker rupee and fresh foreign fund outflows. ...
- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- Jeremy Clarkson cancer: The ‘aggressive’ diagnosis he caught early and the symptoms men shouldn’t ignoreJeremy Clarkson has revealed his diagnosis with an aggressive form of prostate cancer, detected last summer and treated with surgery. Prost...
- Novartis India launches Pluvicto for prostate cancer treatmentNovartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
Load More
